OMEGA HEALTHCARE INVESTORS INVESTOR PRESENTATION February 2021 Disclaimers; Forward-looking Statements and Non-GAAP Information • This presentation may include projections and other "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements relate to future events and expectations and involve unknown risks and uncertainties. Omega's actual results or actions may differ materially from those projected in the forward-looking statements. For a summa ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Exact Name of Registrant as Specified in its Charter) (Omega Healthcare Investors, Inc.) (Omega Healthcare Investors, Inc.) (Omega Healthcare Investors, Inc.) (State or other jurisdiction of incorporation Maryland 1-11316 38-3041398 (Commission file number) (IRS Employer Identification No.) or organization) 303 Internation ...

Omega Healthcare Investors, Inc. (NYSE:OHI) Q4 2020 Earnings Conference Call February 5, 2021 10:00 AM ET Company Participants Michele Reber - Senior Director, Asset Management Taylor Pickett - Chief Executive Officer Bob Stephenson - Chief Financial Officer Dan Booth - Chief Operating Officer Megan Krull - Senior Vice President, Operations Steven Insoft - Chief Corporate Development Officer Conference Call Participants Connor Siversky - Berenberg Aaron Hecht - JMP Securities Jonathan Hughes - Raymond James ...

OMEGA HEALTHCARE INVESTORS INVESTOR PRESENTATION NOVEMBER 2020 Disclaimers; Forward-looking Statements and Non-GAAP Information • This presentation may include projections and other "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements relate to future events and expectations and involve unknown risks and uncertainties. Omega's actual results or actions may differ materially from those projected in the forwardlooking statements. For a summar ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OMEGA HEALTHCARE INVESTORS, INC. OHI HEALTHCARE PROPERTIES LIMITED PARTNERSHIP (Exact name of registrant as specified in its charter) ...

Omega Healthcare Investors, Inc. (NYSE:OHI) Q3 2020 Earnings Conference Call October 30, 2020 10:00 AM ET Company Participants Michele Reber - Senior Director, Asset Management Taylor Pickett - CEO Bob Stephenson - CFO Dan Booth - COO Megan Krull - SVP, Operations Steven Insoft - Chief Corporate Development Officer Conference Call Participants Tayo Okusanya - Mizuho Nicholas Yulico - Scotiabank Connor Siversky - Berenberg Daniel Bernstein - Capital One Nick Joseph - Citi Rich Anderson - SMBC Lukas Hartwich ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OMEGA HEALTHCARE INVESTORS, INC. OHI HEALTHCARE PROPERTIES LIMITED PARTNERSHIP (Exact name of registrant as specified in its charter) (OHI ...

Omega Healthcare Investors, Inc. (NYSE:OHI) Q2 2020 Earnings Conference Call August 6, 2020 10:00 AM ET Company Participants Michele Reber - Senior Director, Asset Management Taylor Pickett - Chief Executive Officer Bob Stephenson - Chief Financial Officer Dan Booth - Chief Operating Officer Megan Krull - Senior Vice President, Operations Steven Insoft - Chief Corporate Development Officer Conference Call Participants Connor Siversky - Berenberg Jonathan Hughes - Raymond James Nick Yulico - Scotiabank Danie ...

PART I Financial Information [Item 1. Financial Statements](index=5&type=section&id=Item%201.%20Financial%20Statements) The report presents unaudited consolidated financial statements for the quarter ended March 31, 2020 Omega Healthcare Investors, Inc. - Key Financial Highlights (Q1 2020 vs Q1 2019) | Metric | Q1 2020 (in thousands) | Q1 2019 (in thousands) | Change | | :--- | :--- | :--- | :--- | | **Total Operating Revenues** | $253,024 | $223,688 | +13.1% | | **Operating Income** | $147,730 | $122,175 | +21.0% | | **Net Income** | $92,279 | $72,182 | +27.8% | | **Net Income available to common stockholders** | $89,915 | $69,702 | +29.0% | | **Diluted EPS** | $0.39 | $0.34 | +14.7% | Omega Healthcare Investors, Inc. - Consolidated Balance Sheet Summary | Metric | March 31, 2020 (in thousands) | December 31, 2019 (in thousands) | | :--- | :--- | :--- | | **Total Assets** | $10,037,231 | $9,796,124 | | **Total Liabilities** | $5,818,586 | $5,459,530 | | **Total Equity** | $4,218,645 | $4,336,594 | Omega Healthcare Investors, Inc. - Consolidated Cash Flow Summary (Q1 2020) | Cash Flow Activity | Amount (in thousands) | | :--- | :--- | | **Net cash provided by operating activities** | $139,068 | | **Net cash used in investing activities** | ($55,154) | | **Net cash provided by financing activities** | $235,157 | | **Increase in cash, cash equivalents and restricted cash** | $318,642 | - The company adopted ASU 2016-13 (Credit Losses) on January 1, 2020, recording an initial **$28.8 million allowance for expected credit losses** with a corresponding adjustment to equity[77](index=77&type=chunk) [Notes to Consolidated Financial Statements](index=17&type=section&id=Notes%20to%20Consolidated%20Financial%20Statements) Notes detail accounting policies, business overview, and the financial impact of the COVID-19 pandemic - Omega's core business is providing financing and capital to the long-term healthcare industry, primarily through **triple-net leases and mortgage agreements** for skilled nursing facilities (SNFs) and assisted living facilities (ALFs) in the U.S. and U.K[38](index=38&type=chunk) - The COVID-19 pandemic is causing **significant cost increases and occupancy declines** for many of the company's operators, which could materially impact their ability to pay rent[45](index=45&type=chunk) - As of March 31, 2020, investments with one operator, Ciena Healthcare, **exceeded 10% of total investments** and generated approximately **10% of total revenues** for the quarter[120](index=120&type=chunk) - On March 20, 2020, the Board authorized a **$200 million stock repurchase program** and the company suspended its Dividend Reinvestment and Common Stock Purchase Plan on March 23, 2020[121](index=121&type=chunk)[125](index=125&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=55&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management analyzes a Q1 2020 revenue increase, the impact of COVID-19, and the company's capital strategy - Operating revenues for Q1 2020 **increased by $29.3 million** compared to Q1 2019, primarily due to rental income from the MedEquities Merger ($10.3 million) and the Encore Portfolio Acquisition ($18.1 million)[228](index=228&type=chunk) - In response to COVID-19 uncertainty, the company took precautionary measures to enhance its capital position, including **drawing $300 million on its revolving credit facility** and entering into **$400 million of forward-starting interest rate swaps**[179](index=179&type=chunk)[247](index=247&type=chunk) - The company is actively restructuring its portfolio with operator Daybreak, which did not pay rent in Q1 2020, with an expected annual rent or equivalent of **$15 million to $20 million post-restructuring**[242](index=242&type=chunk)[244](index=244&type=chunk) Nareit FFO Reconciliation (in thousands) | Description | Q1 2020 | Q1 2019 | | :--- | :--- | :--- | | Net income | $92,279 | $72,182 | | Adjustments (Depreciation, Impairments, etc.) | $88,734 | $71,937 | | **Nareit FFO** | **$181,013** | **$144,119** | [Quantitative and Qualitative Disclosures About Market Risk](index=82&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company reports no material changes to its primary market risk exposures during the first quarter of 2020 - There were **no material changes** in primary market risk exposures or how those exposures are managed during the quarter ended March 31, 2020[261](index=261&type=chunk) [Controls and Procedures](index=83&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that disclosure controls and procedures were effective as of the quarter-end - The Chief Executive Officer and Chief Financial Officer concluded that the company's **disclosure controls and procedures were effective** as of March 31, 2020[263](index=263&type=chunk) - **No changes in internal control over financial reporting** occurred during the quarter that materially affected, or are reasonably likely to materially affect, the company's internal controls[264](index=264&type=chunk) PART II Other Information [Legal Proceedings](index=83&type=section&id=Item%201.%20Legal%20Proceedings) The company details ongoing legal matters, including a securities class action lawsuit and related actions - The company is a defendant in a consolidated **securities class action lawsuit** alleging violations of the Securities Exchange Act of 1934 related to disclosures about an operator's financial condition[151](index=151&type=chunk) - Several related shareholder derivative actions have been filed, which are **currently stayed** pending the outcome of the securities class action appeal[153](index=153&type=chunk)[154](index=154&type=chunk) [Risk Factors](index=83&type=section&id=Item%201A.%20Risk%20Factors) A new risk factor highlights the potential material adverse effects of the COVID-19 pandemic on operations - A new risk factor highlights that the COVID-19 pandemic could have a **material adverse effect** on the company's business, results of operations, cash flows, and financial condition[267](index=267&type=chunk) - Operators are experiencing **significant cost increases and declining occupancy** due to the pandemic, which could affect their ability to pay rent and other contractual obligations to Omega[268](index=268&type=chunk) - The pandemic has caused severe economic and market disruptions, which could **constrain Omega's access to capital** and affect the availability and terms of future financing[270](index=270&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=84&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company discloses the issuance of unregistered shares and the authorization of a stock repurchase program - In Q1 2020, Omega issued **8,060 shares of common stock** in exchange for an equal number of Omega OP Units tendered for redemption, in a transaction exempt from registration[272](index=272&type=chunk) - On March 20, 2020, the company authorized a stock repurchase program for up to **$200 million of its common stock** over twelve months, with no shares repurchased through March 31, 2020[273](index=273&type=chunk) [Exhibits](index=87&type=section&id=Item%206.%20Exhibits) This section lists all exhibits filed with the report, including credit agreements and CEO/CFO certifications - The report includes several exhibits, such as amendments to credit agreements, **CEO/CFO certifications** pursuant to SEC rules, and XBRL data files for interactive data[274](index=274&type=chunk)

Supplemental Information Q1 2020 Table of Contents Portfolio Investment Summary ............................................3 Revenue Summary ................................................3 Operator Payor Mix and Coverage Summary........3 Rent/Interest Concentration by Operator ............4 Lease and Mortgage Expirations...........................4 Diversification Operator Geographic Diversification ....................5 Selected Metrics Occupancy by State...............................................5 ...